It was shown that rCpstefin had a potential modulatory effect on macrophage inflammation, which suggested that rCpstefin could be further applied to the study of autoimmune diseases characterized by a significant increase in IL-1β, IL-6, and TNF-α, such as inflammatory bowel inflammation. Here, IL1B is linked to autoimmune disease.